Latin American Expert Consensus for Comprehensive Management of Type 2 Diabetes from a Metabolic–Cardio–Renal Perspective for the Primary Care Physician

被引：0

作者：

Roopa Mehta

Daniel Pichel

Chih Hao Chen-Ku

Pablo Raffaele

Antonio Méndez Durán

Francisco Padilla

Jose Javier Arango Alvarez

José Esteban Costa Gil

Juan Esteban Gómez Mesa

Mariano Giorgi

Rodolfo Lahsen

Andrei C. Sposito

机构：

[1] National Institute of Medical Sciences and Nutrition Salvador Zubirán (INCMNSZ),Metabolic Diseases Research Unit (UIEM)

[2] Hospital Paitilla,Department of Medicine/Cardiology

[3] Clínica Los Yoses,Department of Nephrology

[4] San Pedro Montes de Oca,Coordinacion de Planeacion de Infraestructura Medica

[5] Fundación Favaloro University Hospital,Internal Medicine/Cardiology

[6] Instituto Mexicano del Seguro Social,Cardiology Section, Cardiovascular Prevention Unit

[7] Cardiología Clínica e Intervencionista,Centro de Diabetes Adultos

[8] Clinica del Café,Department of Cardiology

[9] Instituto de Cardiología y Cirugía Cardiovascular,undefined

[10] Fundación Valle del Lili,undefined

[11] CEMIC,undefined

[12] Clinica Las Condes,undefined

[13] State University of Campinas (Unicamp),undefined

来源：

Diabetes Therapy | 2021年 / 12卷

关键词：

Antidiabetic drugs; Cardiovascular disease; Heart failure; Hypoglycemia; Type 2 diabetes mellitus;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Growing scientific evidence from studies on type 2 diabetes (T2D) has recently led to a better understanding of the associated metabolic–cardio–renal risks. The large amount of available information makes it essential to have a practical guide that summarizes the recommendations for the initial management of patients with T2D, integrating different aspects of endocrinology, cardiology, and nephrology. The expert consensus presented here does not attempt to summarize all the evidence in this regard but rather attempts to define practical summary recommendations for the primary care physician to improve the clinical prognosis and management of patients with T2D, while ensuring economic sustainability of health systems, beyond glycemic control.

引用

页码：1 / 20

页数：19

共 242 条

[21]

Shubrook JH(2016)Practical approach to detection and management of chronic kidney disease for the primary care clinician Am J Med 129 153-140

[22]

Lavernia F(2020)Microvascular complications and foot care: standards of medical care in diabetes− 2020 Diabetes Care 43 S135-323

[23]

van Bruggen R(2011)Addressing cardiovascular risk in patients with type 2 diabetes: focus on primary care Am J Med Sci 341 132-471

[24]

Gorter K(2016)Microvascular endothelial dysfunction is associated with albuminuria and CKD in older adults BMC Nephrol 17 82-1640

[25]

Stolk RP(2020)2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD Eur Heart J 41 255-493

[26]

Zuithoff P(2010)Treatment of type 2 diabetes in Latin America: a consensus statement by the medical associations of 17 Latin American countries Rev Panam Salud Pública 28 463-865

[27]

Klungel OH(2017)International consensus on use of continuous glucose monitoring Diabetes Care 40 1631-1589

[28]

Rutten GEHM(2020)2019 update to: Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Diabetes Care 43 487-2128

[29]

Lopez Stewart G(1998)Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet 352 854-357

[30]

Tambascia M(2008)10-Year follow-up of intensive glucose control in type 2 diabetes N Engl J Med 359 1577-2031

← 1 2 3 4 5 6 7 8 9 10 →